nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—Lisinopril—systemic scleroderma	0.125	0.275	CbGbCtD
Meprobamate—ABCB1—Captopril—systemic scleroderma	0.0936	0.206	CbGbCtD
Meprobamate—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0737	0.162	CbGbCtD
Meprobamate—CYP2C19—Prednisone—systemic scleroderma	0.073	0.161	CbGbCtD
Meprobamate—ABCB1—Prednisone—systemic scleroderma	0.0589	0.13	CbGbCtD
Meprobamate—ABCB1—Methotrexate—systemic scleroderma	0.0296	0.0651	CbGbCtD
Meprobamate—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.004	0.00732	CcSEcCtD
Meprobamate—Bronchospasm—Mometasone—systemic scleroderma	0.00395	0.00724	CcSEcCtD
Meprobamate—Lymphadenopathy—Leflunomide—systemic scleroderma	0.00394	0.00722	CcSEcCtD
Meprobamate—Ataxia—Captopril—systemic scleroderma	0.00384	0.00703	CcSEcCtD
Meprobamate—Oliguria—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00694	CcSEcCtD
Meprobamate—Lymphadenopathy—Mycophenolic acid—systemic scleroderma	0.00376	0.00689	CcSEcCtD
Meprobamate—Eosinophilia—Captopril—systemic scleroderma	0.00349	0.0064	CcSEcCtD
Meprobamate—Bronchospasm—Captopril—systemic scleroderma	0.00347	0.00636	CcSEcCtD
Meprobamate—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.00336	0.00615	CcSEcCtD
Meprobamate—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00333	0.0061	CcSEcCtD
Meprobamate—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00328	0.006	CcSEcCtD
Meprobamate—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.00317	0.00581	CcSEcCtD
Meprobamate—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00578	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00312	0.00571	CcSEcCtD
Meprobamate—Stomatitis—Captopril—systemic scleroderma	0.00307	0.00562	CcSEcCtD
Meprobamate—Ataxia—Mycophenolic acid—systemic scleroderma	0.00302	0.00553	CcSEcCtD
Meprobamate—Agitation—Pentoxifylline—systemic scleroderma	0.00298	0.00546	CcSEcCtD
Meprobamate—Lymphadenopathy—Mycophenolate mofetil—systemic scleroderma	0.00297	0.00544	CcSEcCtD
Meprobamate—Angioedema—Pentoxifylline—systemic scleroderma	0.00296	0.00543	CcSEcCtD
Meprobamate—Agranulocytosis—Captopril—systemic scleroderma	0.00294	0.00538	CcSEcCtD
Meprobamate—Leukopenia—Pentoxifylline—systemic scleroderma	0.0029	0.00532	CcSEcCtD
Meprobamate—Eosinophilia—Leflunomide—systemic scleroderma	0.00288	0.00527	CcSEcCtD
Meprobamate—Petechiae—Prednisone—systemic scleroderma	0.00288	0.00527	CcSEcCtD
Meprobamate—Palpitations—Pentoxifylline—systemic scleroderma	0.00287	0.00525	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00272	0.00499	CcSEcCtD
Meprobamate—Ataxia—Lisinopril—systemic scleroderma	0.00272	0.00498	CcSEcCtD
Meprobamate—Erythema multiforme—Captopril—systemic scleroderma	0.00267	0.00489	CcSEcCtD
Meprobamate—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00486	CcSEcCtD
Meprobamate—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00265	0.00485	CcSEcCtD
Meprobamate—Shock—Pentoxifylline—systemic scleroderma	0.0026	0.00477	CcSEcCtD
Meprobamate—Tachycardia—Pentoxifylline—systemic scleroderma	0.00258	0.00473	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00257	0.00471	CcSEcCtD
Meprobamate—Agranulocytosis—Azathioprine—systemic scleroderma	0.00256	0.00469	CcSEcCtD
Meprobamate—Angioedema—Mometasone—systemic scleroderma	0.00256	0.00469	CcSEcCtD
Meprobamate—Stomatitis—Leflunomide—systemic scleroderma	0.00253	0.00463	CcSEcCtD
Meprobamate—Eosinophilia—Lisinopril—systemic scleroderma	0.00247	0.00453	CcSEcCtD
Meprobamate—Hypotension—Pentoxifylline—systemic scleroderma	0.00247	0.00453	CcSEcCtD
Meprobamate—Bronchospasm—Lisinopril—systemic scleroderma	0.00246	0.0045	CcSEcCtD
Meprobamate—Agranulocytosis—Leflunomide—systemic scleroderma	0.00242	0.00443	CcSEcCtD
Meprobamate—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00241	0.00442	CcSEcCtD
Meprobamate—Petechiae—Methotrexate—systemic scleroderma	0.0024	0.0044	CcSEcCtD
Meprobamate—Somnolence—Pentoxifylline—systemic scleroderma	0.00235	0.00431	CcSEcCtD
Meprobamate—Erythema multiforme—Azathioprine—systemic scleroderma	0.00233	0.00427	CcSEcCtD
Meprobamate—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00231	0.00423	CcSEcCtD
Meprobamate—Oedema peripheral—Leflunomide—systemic scleroderma	0.00229	0.0042	CcSEcCtD
Meprobamate—Anaphylactic shock—Mometasone—systemic scleroderma	0.00228	0.00419	CcSEcCtD
Meprobamate—Angioedema—Captopril—systemic scleroderma	0.00225	0.00412	CcSEcCtD
Meprobamate—Chills—Azathioprine—systemic scleroderma	0.00221	0.00405	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00221	0.00405	CcSEcCtD
Meprobamate—Syncope—Captopril—systemic scleroderma	0.0022	0.00404	CcSEcCtD
Meprobamate—Arrhythmia—Azathioprine—systemic scleroderma	0.0022	0.00403	CcSEcCtD
Meprobamate—Erythema multiforme—Leflunomide—systemic scleroderma	0.0022	0.00403	CcSEcCtD
Meprobamate—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00219	0.00401	CcSEcCtD
Meprobamate—Palpitations—Captopril—systemic scleroderma	0.00217	0.00398	CcSEcCtD
Meprobamate—Loss of consciousness—Captopril—systemic scleroderma	0.00216	0.00396	CcSEcCtD
Meprobamate—Oliguria—Methotrexate—systemic scleroderma	0.00215	0.00393	CcSEcCtD
Meprobamate—Ecchymosis—Prednisone—systemic scleroderma	0.00214	0.00392	CcSEcCtD
Meprobamate—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00209	0.00383	CcSEcCtD
Meprobamate—Dysarthria—Methotrexate—systemic scleroderma	0.00209	0.00383	CcSEcCtD
Meprobamate—Chills—Leflunomide—systemic scleroderma	0.00209	0.00383	CcSEcCtD
Meprobamate—Arrhythmia—Leflunomide—systemic scleroderma	0.00208	0.00381	CcSEcCtD
Meprobamate—Agranulocytosis—Lisinopril—systemic scleroderma	0.00208	0.00381	CcSEcCtD
Meprobamate—Paraesthesia—Mometasone—systemic scleroderma	0.00205	0.00376	CcSEcCtD
Meprobamate—Euphoric mood—Prednisone—systemic scleroderma	0.00203	0.00372	CcSEcCtD
Meprobamate—Anaphylactic shock—Captopril—systemic scleroderma	0.00201	0.00368	CcSEcCtD
Meprobamate—Chills—Mycophenolic acid—systemic scleroderma	0.00199	0.00365	CcSEcCtD
Meprobamate—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00198	0.00363	CcSEcCtD
Meprobamate—Shock—Captopril—systemic scleroderma	0.00197	0.00362	CcSEcCtD
Meprobamate—Oedema peripheral—Lisinopril—systemic scleroderma	0.00197	0.00361	CcSEcCtD
Meprobamate—Tachycardia—Captopril—systemic scleroderma	0.00196	0.00359	CcSEcCtD
Meprobamate—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00195	0.00357	CcSEcCtD
Meprobamate—Leukopenia—Azathioprine—systemic scleroderma	0.00192	0.00352	CcSEcCtD
Meprobamate—Vascular purpura—Prednisone—systemic scleroderma	0.00192	0.00352	CcSEcCtD
Meprobamate—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.0019	0.00349	CcSEcCtD
Meprobamate—Asthenia—Pentoxifylline—systemic scleroderma	0.0019	0.00348	CcSEcCtD
Meprobamate—Erythema multiforme—Lisinopril—systemic scleroderma	0.00189	0.00346	CcSEcCtD
Meprobamate—Hypotension—Captopril—systemic scleroderma	0.00188	0.00343	CcSEcCtD
Meprobamate—Pruritus—Pentoxifylline—systemic scleroderma	0.00187	0.00343	CcSEcCtD
Meprobamate—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00186	0.0034	CcSEcCtD
Meprobamate—Angioedema—Leflunomide—systemic scleroderma	0.00185	0.00339	CcSEcCtD
Meprobamate—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00334	CcSEcCtD
Meprobamate—Vertigo—Leflunomide—systemic scleroderma	0.00182	0.00334	CcSEcCtD
Meprobamate—Leukopenia—Leflunomide—systemic scleroderma	0.00181	0.00332	CcSEcCtD
Meprobamate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00181	0.00332	CcSEcCtD
Meprobamate—Body temperature increased—Mometasone—systemic scleroderma	0.00181	0.00331	CcSEcCtD
Meprobamate—Paraesthesia—Captopril—systemic scleroderma	0.0018	0.0033	CcSEcCtD
Meprobamate—Chills—Lisinopril—systemic scleroderma	0.00179	0.00329	CcSEcCtD
Meprobamate—Palpitations—Leflunomide—systemic scleroderma	0.00179	0.00328	CcSEcCtD
Meprobamate—Ecchymosis—Methotrexate—systemic scleroderma	0.00179	0.00327	CcSEcCtD
Meprobamate—Arrhythmia—Lisinopril—systemic scleroderma	0.00179	0.00327	CcSEcCtD
Meprobamate—Somnolence—Captopril—systemic scleroderma	0.00178	0.00327	CcSEcCtD
Meprobamate—Purpura—Prednisone—systemic scleroderma	0.00178	0.00326	CcSEcCtD
Meprobamate—Agitation—Mycophenolic acid—systemic scleroderma	0.00178	0.00325	CcSEcCtD
Meprobamate—Dizziness—Pentoxifylline—systemic scleroderma	0.00175	0.00321	CcSEcCtD
Meprobamate—Vertigo—Mycophenolic acid—systemic scleroderma	0.00174	0.00318	CcSEcCtD
Meprobamate—Syncope—Mycophenolic acid—systemic scleroderma	0.00173	0.00318	CcSEcCtD
Meprobamate—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00173	0.00317	CcSEcCtD
Meprobamate—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00316	CcSEcCtD
Meprobamate—Palpitations—Mycophenolic acid—systemic scleroderma	0.00171	0.00313	CcSEcCtD
Meprobamate—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0017	0.00311	CcSEcCtD
Meprobamate—Vomiting—Pentoxifylline—systemic scleroderma	0.00168	0.00308	CcSEcCtD
Meprobamate—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00168	0.00308	CcSEcCtD
Meprobamate—Dermatitis—Pentoxifylline—systemic scleroderma	0.00167	0.00306	CcSEcCtD
Meprobamate—Headache—Pentoxifylline—systemic scleroderma	0.00166	0.00304	CcSEcCtD
Meprobamate—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00165	0.00303	CcSEcCtD
Meprobamate—Asthenia—Mometasone—systemic scleroderma	0.00164	0.003	CcSEcCtD
Meprobamate—Hypotension—Azathioprine—systemic scleroderma	0.00164	0.003	CcSEcCtD
Meprobamate—Pruritus—Mometasone—systemic scleroderma	0.00162	0.00296	CcSEcCtD
Meprobamate—Tachycardia—Leflunomide—systemic scleroderma	0.00161	0.00296	CcSEcCtD
Meprobamate—Angioedema—Lisinopril—systemic scleroderma	0.00159	0.00291	CcSEcCtD
Meprobamate—Body temperature increased—Captopril—systemic scleroderma	0.00159	0.00291	CcSEcCtD
Meprobamate—Nausea—Pentoxifylline—systemic scleroderma	0.00157	0.00288	CcSEcCtD
Meprobamate—Chills—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00288	CcSEcCtD
Meprobamate—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00287	CcSEcCtD
Meprobamate—Vertigo—Lisinopril—systemic scleroderma	0.00156	0.00287	CcSEcCtD
Meprobamate—Diarrhoea—Mometasone—systemic scleroderma	0.00156	0.00286	CcSEcCtD
Meprobamate—Syncope—Lisinopril—systemic scleroderma	0.00156	0.00286	CcSEcCtD
Meprobamate—Leukopenia—Lisinopril—systemic scleroderma	0.00156	0.00286	CcSEcCtD
Meprobamate—Shock—Mycophenolic acid—systemic scleroderma	0.00155	0.00284	CcSEcCtD
Meprobamate—Hypotension—Leflunomide—systemic scleroderma	0.00155	0.00283	CcSEcCtD
Meprobamate—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00154	0.00282	CcSEcCtD
Meprobamate—Palpitations—Lisinopril—systemic scleroderma	0.00154	0.00282	CcSEcCtD
Meprobamate—Loss of consciousness—Lisinopril—systemic scleroderma	0.00153	0.0028	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00152	0.00279	CcSEcCtD
Meprobamate—Paraesthesia—Leflunomide—systemic scleroderma	0.00149	0.00272	CcSEcCtD
Meprobamate—Hypotension—Mycophenolic acid—systemic scleroderma	0.00147	0.0027	CcSEcCtD
Meprobamate—Vomiting—Mometasone—systemic scleroderma	0.00145	0.00266	CcSEcCtD
Meprobamate—Asthenia—Captopril—systemic scleroderma	0.00144	0.00264	CcSEcCtD
Meprobamate—Dermatitis—Mometasone—systemic scleroderma	0.00144	0.00264	CcSEcCtD
Meprobamate—Headache—Mometasone—systemic scleroderma	0.00143	0.00262	CcSEcCtD
Meprobamate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00142	0.0026	CcSEcCtD
Meprobamate—Pruritus—Captopril—systemic scleroderma	0.00142	0.0026	CcSEcCtD
Meprobamate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00142	0.0026	CcSEcCtD
Meprobamate—Somnolence—Mycophenolic acid—systemic scleroderma	0.0014	0.00257	CcSEcCtD
Meprobamate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00257	CcSEcCtD
Meprobamate—Shock—Lisinopril—systemic scleroderma	0.0014	0.00256	CcSEcCtD
Meprobamate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00255	CcSEcCtD
Meprobamate—Tachycardia—Lisinopril—systemic scleroderma	0.00139	0.00254	CcSEcCtD
Meprobamate—Body temperature increased—Azathioprine—systemic scleroderma	0.00138	0.00254	CcSEcCtD
Meprobamate—Diarrhoea—Captopril—systemic scleroderma	0.00137	0.00252	CcSEcCtD
Meprobamate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00251	CcSEcCtD
Meprobamate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00251	CcSEcCtD
Meprobamate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.0025	CcSEcCtD
Meprobamate—Nausea—Mometasone—systemic scleroderma	0.00136	0.00249	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—systemic scleroderma	0.00135	0.00247	CcSEcCtD
Meprobamate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00247	CcSEcCtD
Meprobamate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00246	CcSEcCtD
Meprobamate—Hypotension—Lisinopril—systemic scleroderma	0.00133	0.00243	CcSEcCtD
Meprobamate—Dizziness—Captopril—systemic scleroderma	0.00133	0.00243	CcSEcCtD
Meprobamate—Body temperature increased—Leflunomide—systemic scleroderma	0.00131	0.00239	CcSEcCtD
Meprobamate—Hypersensitivity—Azathioprine—systemic scleroderma	0.00129	0.00236	CcSEcCtD
Meprobamate—Paraesthesia—Lisinopril—systemic scleroderma	0.00128	0.00234	CcSEcCtD
Meprobamate—Vomiting—Captopril—systemic scleroderma	0.00128	0.00234	CcSEcCtD
Meprobamate—Dermatitis—Captopril—systemic scleroderma	0.00126	0.00232	CcSEcCtD
Meprobamate—Somnolence—Lisinopril—systemic scleroderma	0.00126	0.00231	CcSEcCtD
Meprobamate—Headache—Captopril—systemic scleroderma	0.00126	0.0023	CcSEcCtD
Meprobamate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00125	0.00228	CcSEcCtD
Meprobamate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00228	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—systemic scleroderma	0.00123	0.00225	CcSEcCtD
Meprobamate—Shock—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00224	CcSEcCtD
Meprobamate—Hypersensitivity—Leflunomide—systemic scleroderma	0.00122	0.00223	CcSEcCtD
Meprobamate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00223	CcSEcCtD
Meprobamate—Diarrhoea—Azathioprine—systemic scleroderma	0.0012	0.00219	CcSEcCtD
Meprobamate—Nausea—Captopril—systemic scleroderma	0.00119	0.00218	CcSEcCtD
Meprobamate—Asthenia—Leflunomide—systemic scleroderma	0.00119	0.00217	CcSEcCtD
Meprobamate—Pruritus—Leflunomide—systemic scleroderma	0.00117	0.00214	CcSEcCtD
Meprobamate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00213	CcSEcCtD
Meprobamate—Dizziness—Azathioprine—systemic scleroderma	0.00116	0.00212	CcSEcCtD
Meprobamate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00113	0.00207	CcSEcCtD
Meprobamate—Diarrhoea—Leflunomide—systemic scleroderma	0.00113	0.00207	CcSEcCtD
Meprobamate—Body temperature increased—Lisinopril—systemic scleroderma	0.00112	0.00206	CcSEcCtD
Meprobamate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00205	CcSEcCtD
Meprobamate—Pruritus—Mycophenolic acid—systemic scleroderma	0.00112	0.00204	CcSEcCtD
Meprobamate—Vomiting—Azathioprine—systemic scleroderma	0.00111	0.00204	CcSEcCtD
Meprobamate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00203	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—systemic scleroderma	0.00111	0.00203	CcSEcCtD
Meprobamate—Dermatitis—Azathioprine—systemic scleroderma	0.0011	0.00202	CcSEcCtD
Meprobamate—Headache—Azathioprine—systemic scleroderma	0.0011	0.00201	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.0011	0.00201	CcSEcCtD
Meprobamate—Dizziness—Leflunomide—systemic scleroderma	0.00109	0.002	CcSEcCtD
Meprobamate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00108	0.00198	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—systemic scleroderma	0.00108	0.00197	CcSEcCtD
Meprobamate—Arrhythmia—Prednisone—systemic scleroderma	0.00106	0.00194	CcSEcCtD
Meprobamate—Vomiting—Leflunomide—systemic scleroderma	0.00105	0.00193	CcSEcCtD
Meprobamate—Hypersensitivity—Lisinopril—systemic scleroderma	0.00105	0.00192	CcSEcCtD
Meprobamate—Dizziness—Mycophenolic acid—systemic scleroderma	0.00104	0.00191	CcSEcCtD
Meprobamate—Dermatitis—Leflunomide—systemic scleroderma	0.00104	0.00191	CcSEcCtD
Meprobamate—Nausea—Azathioprine—systemic scleroderma	0.00104	0.00191	CcSEcCtD
Meprobamate—Headache—Leflunomide—systemic scleroderma	0.00104	0.0019	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—systemic scleroderma	0.00103	0.00189	CcSEcCtD
Meprobamate—Asthenia—Lisinopril—systemic scleroderma	0.00102	0.00187	CcSEcCtD
Meprobamate—Pruritus—Lisinopril—systemic scleroderma	0.00101	0.00184	CcSEcCtD
Meprobamate—Vomiting—Mycophenolic acid—systemic scleroderma	0.001	0.00184	CcSEcCtD
Meprobamate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000994	0.00182	CcSEcCtD
Meprobamate—Headache—Mycophenolic acid—systemic scleroderma	0.000988	0.00181	CcSEcCtD
Meprobamate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000984	0.0018	CcSEcCtD
Meprobamate—Nausea—Leflunomide—systemic scleroderma	0.000982	0.0018	CcSEcCtD
Meprobamate—Diarrhoea—Lisinopril—systemic scleroderma	0.000972	0.00178	CcSEcCtD
Meprobamate—Agitation—Prednisone—systemic scleroderma	0.00095	0.00174	CcSEcCtD
Meprobamate—Angioedema—Prednisone—systemic scleroderma	0.000945	0.00173	CcSEcCtD
Meprobamate—Dizziness—Lisinopril—systemic scleroderma	0.00094	0.00172	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000939	0.00172	CcSEcCtD
Meprobamate—Nausea—Mycophenolic acid—systemic scleroderma	0.000937	0.00172	CcSEcCtD
Meprobamate—Vertigo—Prednisone—systemic scleroderma	0.000929	0.0017	CcSEcCtD
Meprobamate—Syncope—Prednisone—systemic scleroderma	0.000927	0.0017	CcSEcCtD
Meprobamate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00168	CcSEcCtD
Meprobamate—Loss of consciousness—Prednisone—systemic scleroderma	0.000909	0.00166	CcSEcCtD
Meprobamate—Vomiting—Lisinopril—systemic scleroderma	0.000904	0.00166	CcSEcCtD
Meprobamate—Dermatitis—Lisinopril—systemic scleroderma	0.000895	0.00164	CcSEcCtD
Meprobamate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00164	CcSEcCtD
Meprobamate—Chills—Methotrexate—systemic scleroderma	0.000891	0.00163	CcSEcCtD
Meprobamate—Headache—Lisinopril—systemic scleroderma	0.00089	0.00163	CcSEcCtD
Meprobamate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000881	0.00161	CcSEcCtD
Meprobamate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000852	0.00156	CcSEcCtD
Meprobamate—Nausea—Lisinopril—systemic scleroderma	0.000844	0.00155	CcSEcCtD
Meprobamate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000844	0.00155	CcSEcCtD
Meprobamate—Shock—Prednisone—systemic scleroderma	0.00083	0.00152	CcSEcCtD
Meprobamate—Tachycardia—Prednisone—systemic scleroderma	0.000824	0.00151	CcSEcCtD
Meprobamate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000823	0.00151	CcSEcCtD
Meprobamate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000792	0.00145	CcSEcCtD
Meprobamate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000784	0.00144	CcSEcCtD
Meprobamate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00143	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—systemic scleroderma	0.000776	0.00142	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—systemic scleroderma	0.000774	0.00142	CcSEcCtD
Meprobamate—Paraesthesia—Prednisone—systemic scleroderma	0.000758	0.00139	CcSEcCtD
Meprobamate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00135	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000705	0.00129	CcSEcCtD
Meprobamate—Body temperature increased—Prednisone—systemic scleroderma	0.000667	0.00122	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—systemic scleroderma	0.000659	0.00121	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—systemic scleroderma	0.000633	0.00116	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—systemic scleroderma	0.000627	0.00115	CcSEcCtD
Meprobamate—Hypersensitivity—Prednisone—systemic scleroderma	0.000622	0.00114	CcSEcCtD
Meprobamate—Asthenia—Prednisone—systemic scleroderma	0.000606	0.00111	CcSEcCtD
Meprobamate—Pruritus—Prednisone—systemic scleroderma	0.000597	0.00109	CcSEcCtD
Meprobamate—Diarrhoea—Prednisone—systemic scleroderma	0.000577	0.00106	CcSEcCtD
Meprobamate—Dizziness—Prednisone—systemic scleroderma	0.000558	0.00102	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—systemic scleroderma	0.000558	0.00102	CcSEcCtD
Meprobamate—Vomiting—Prednisone—systemic scleroderma	0.000537	0.000983	CcSEcCtD
Meprobamate—Dermatitis—Prednisone—systemic scleroderma	0.000532	0.000974	CcSEcCtD
Meprobamate—Headache—Prednisone—systemic scleroderma	0.000529	0.000969	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—systemic scleroderma	0.00052	0.000952	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—systemic scleroderma	0.000506	0.000927	CcSEcCtD
Meprobamate—Nausea—Prednisone—systemic scleroderma	0.000501	0.000918	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—systemic scleroderma	0.000499	0.000914	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—systemic scleroderma	0.000483	0.000884	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—systemic scleroderma	0.000466	0.000854	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—systemic scleroderma	0.000448	0.000822	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—systemic scleroderma	0.000444	0.000814	CcSEcCtD
Meprobamate—Headache—Methotrexate—systemic scleroderma	0.000442	0.000809	CcSEcCtD
Meprobamate—Nausea—Methotrexate—systemic scleroderma	0.000419	0.000767	CcSEcCtD
